journal
https://read.qxmd.com/read/38752864/renal-disease-in-pediatric-rheumatology
#1
JOURNAL ARTICLE
Ellen Cody, Hermine I Brunner
PURPOSE OF REVIEW: This review will provide updates in the outcomes in the common rheumatologic diseases with kidney involvement. Covered are also advances in therapeutics for the use of pediatric rheumatologic diseases with kidney involvement, as well as the potential kidney complications from other rheumatologic diseases and their medications. RECENT FINDINGS: Two of the more common rheumatologic diseases with kidney involvement, lupus and vasculitis, continue to show inadequate response to initial therapy of renal disease and practice continues to be driven by results of adult studies...
May 17, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38747320/updates-in-the-care-and-management-of-children-and-adolescents-with-systemic-lupus-erythematosus
#2
JOURNAL ARTICLE
Clovis A Silva, Nadia E Aikawa, Eloisa Bonfa
PURPOSE OF REVIEW: This narrative review offers an update of the most important recent articles published in the previous year of childhood-onset systemic lupus erythematosus (cSLE), focusing on care and management. RECENT FINDINGS: Age-related disparities may play a significant role in the clinical and laboratory characteristics of cSLE, as well as its performance in distinct classification criteria. Monogenic lupus is associated with higher disease damage scores and mortality rate compared to sporadic cSLE...
May 16, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38712691/disease-modification-in-axial-spondyloarthritis-still-a-controversy
#3
JOURNAL ARTICLE
Manouk de Hooge, Désirée van der Heijde
PURPOSE OF REVIEW: This review evaluates recent advancements in disease-modifying therapies for axial spondyloarthritis (axSpA). RECENT FINDINGS: A recent study could not demonstrate an additional effect of NSAID therapy on golimumab [Tumor Necrosis Factor-α inhibitor (TNFi)] on structural progression; however, this might be due to the fact that the study was underpowered. While DMARDs have shown promise in suppressing inflammation, their impact on structural progression remains uncertain...
May 8, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38695425/investigating-gout-flares-beyond-a-definition
#4
JOURNAL ARTICLE
Charles Sutherland, Angelo L Gaffo
PURPOSE OF REVIEW: Gout flares are a paramount component of disease burden inflicted by gout onto the patient. Furthermore, they are included in the core domain set for long-term gout studies recognized by Outcome Measures in Rheumatology. Along with a validated classification criterion for gout, gout investigators have turned their efforts into defining and characterizing the gout flare. This brief review will summarize the efforts that have been done to define and characterize a gout flare in clinical studies...
May 3, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38690783/navigating-the-complexity-of-pain-in-psoriatic-arthritis-and-axial-spondyloarthritis
#5
JOURNAL ARTICLE
Philip J Mease
PURPOSE OF REVIEW: Pain is the most common and often most troublesome feature of chronic autoimmune diseases such as psoriatic arthritis (PsA) and axial spondyloarthritis (AxSpA). A predominant concept is that the main source of pain is from disease-induced tissue inflammation and structural damage, activating peripheral nerve fibers which relay to the central nervous system. This mechanism is nociceptive pain and the presumption has been that controlling inflammation will be sufficient to reduce this form of pain...
May 2, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38687285/sacroiliitis-in-inflammatory-bowel-disease
#6
JOURNAL ARTICLE
Fardina Malik, Michael H Weisman
PURPOSE OF REVIEW: This review summarizes the recent evidence regarding the epidemiology of inflammatory bowel disease (IBD) associated sacroiliitis, including the prevalence, pathogenesis, role of imaging, and therapeutic challenges. RECENT FINDINGS: Sacroiliitis is an underappreciated musculoskeletal manifestation of IBD, a chronic inflammatory condition of the gut affecting the younger population. Untreated sacroiliitis can lead to joint destruction and chronic pain, further adding to morbidity in IBD patients...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38661436/axial-spondyloarthritis-guidelines-aiming-for-maximum-impact
#7
JOURNAL ARTICLE
Mathieu Choufani, Jonathan Kay, Joerg Ermann
PURPOSE OF REVIEW: This review discusses international clinical practice guidelines (CPGs) for axial spondyloarthritis (axSpA) focusing on methodology, guideline quality, and implementation. RECENT FINDINGS: The Assessment of SpondyloArthritis International Society/European Alliance of Associations for Rheumatology (ASAS/EULAR) and Pan-American League of Associations for Rheumatology (PANLAR) recently published axSpA CPGs and updates of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network (ACR/SAA/SPARTAN) and Asia-Pacific League of Associations for Rheumatology (APLAR) CPGs are expected...
April 26, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38656252/50%C3%A2-years-of-spondyloarthritis-a-look-back-and-a-look-ahead
#8
JOURNAL ARTICLE
Philip S Helliwell
PURPOSE OF REVIEW: It is now 50 years since the concept of spondyloarthritis was introduced by Moll, Wright and co-authors from Leeds, UK. This review will review the original concept and mark significant milestones over the last 50 years while looking ahead to developments in the future. RECENT FINDINGS: While the diseases included under this rubric in the original description may have changed the core conditions remain and are still characterized by axial inflammation as a common feature...
April 25, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38651512/an-update-on-topical-therapies-for-psoriasis
#9
JOURNAL ARTICLE
Emily K Pender, Brian Kirby
PURPOSE OF REVIEW: Topical therapies are a mainstay of treatment for mild psoriasis and may be a useful adjunct in treatment of moderate-to-severe psoriasis. This review summarizes recent advances in topical therapies for psoriasis and currently available treatments. RECENT FINDINGS: Topical aryl hydrocarbon receptor modulators (tapinarof) and topical phosphodiesterase-4 inhibitors (roflumilast) have been proven effective in randomized controlled trials for psoriasis...
April 24, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38639758/drug-therapy-in-juvenile-spondyloarthritis
#10
JOURNAL ARTICLE
Hemalatha Srinivasalu, Jessica Simpson, Matthew L Stoll
PURPOSE OF REVIEW: This review summarizes latest developments in treatment of juvenile spondyloarthritis (JSpA), specifically enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA). RECENT FINDINGS: There has been addition of biologic disease modifying antirheumatic drugs (bDMARDs) beyond tumor necrosis factor inhibitors (TNFi) for JSpA such as IL-17 blockers, IL-23 blockers, and janus activating kinase inhibitors with favorable safety profile...
April 22, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38533807/artificial-intelligence-and-machine-learning-in-axial-spondyloarthritis
#11
JOURNAL ARTICLE
Lisa C Adams, Keno K Bressem, Denis Poddubnyy
PURPOSE OF REVIEW: To evaluate the current applications and prospects of artificial intelligence and machine learning in diagnosing and managing axial spondyloarthritis (axSpA), focusing on their role in medical imaging, predictive modelling, and patient monitoring. RECENT FINDINGS: Artificial intelligence, particularly deep learning, is showing promise in diagnosing axSpA assisting with X-ray, computed tomography (CT) and MRI analyses, with some models matching or outperforming radiologists in detecting sacroiliitis and markers...
March 28, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38517340/describing-calcium-pyrophosphate-deposition-undoing-the-tower-of-babel
#12
REVIEW
Silvia Sirotti, Robert Terkeltaub, Georgios Filippou
PURPOSE OF REVIEW: In 1977, McCarty astutely observed, 'The variety of names suggested for the condition associated with deposits of calcium pyrophosphate dihydrate crystals is exceeded only by the variations of its clinical presentation'. Fast forward to 2024, a standardized nomenclature for calcium pyrophosphate deposition (CPPD) is still lacking. This review aims to delineate the challenges in characterizing CPPD through nomenclature and imaging. RECENT FINDINGS: Despite the effort of nomenclature standardization in 2011 by the EULAR, confusion persists in the literature and clinical practice, with pseudo-forms and obscure abbreviations...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38517339/rheumatoid-arthritis-the-challenge-of-heterogeneity
#13
JOURNAL ARTICLE
David A Fox
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38517338/chimeric-antigen-receptors-cars-in-the-fast-lane-for-rheumatology
#14
REVIEW
Nathan M Johnson, Fotios Koumpouras
PURPOSE OF REVIEW: Recent advances in hematology-oncology have pioneered cell-mediated elimination of pathologic B-cell populations employing chimeric antigen receptor (CAR) T cells. In this review, we discuss recent adoption of CAR-T treatment for severe refractory autoimmune disease. We highlight unique aspects of the autoimmune model and review current clinical data regarding treatment of rheumatologic disease. RECENT FINDINGS: To date, several CAR-Ts are FDA approved for Multiple Myeloma and B-cell malignancies and have demonstrated extraordinary clinical responses in refractory disease...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38517337/sodium-glucose-cotransporter-2-inhibitors-are-they-ready-for-prime-time-in-the-management-of-lupus-nephritis
#15
REVIEW
Benjamin R Wagner, Panduranga S Rao
PURPOSE OF REVIEW: Lupus nephritis is a common complication of systemic lupus erythematosus and is associated with significant morbidity and mortality. The utility of sodium-glucose cotransporter 2 (SGLT2) inhibitors in the management of lupus nephritis is currently uncertain. Here, we summarize the rationale for their use among patient with lupus nephritis. RECENT FINDINGS: SGLT2 inhibitors were initially developed as antihyperglycemic agents. They have since been shown to have additional, profound effects to slow the progression of chronic kidney disease and lessen the long-term risks of cardiovascular disease in large clinic trials of patients with chronic kidney disease, with and without diabetes, as well as in patients with and without proteinuria...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38456470/safety-of-biologic-agents-for-the-management-of-rheumatic-diseases-during-pregnancy
#16
REVIEW
Jonathan D D'Gama, Bonnie L Bermas
PURPOSE OF REVIEW: To discuss the current understanding regarding the use of biologic therapeutics in pregnancy. RECENT FINDINGS: Our understanding of the mechanisms underlying the potential fetal and infant exposure to biologics as well as a growing body of empirical evidence from real world use of biologics in pregnancy have demonstrated that biologics are generally compatible preconception and during pregnancy. Long-term effects of exposure to biologic agents in utero are not known, but will be uncovered in time...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38441488/rheumatoid-arthritis-prediction-of-future-clinically-apparent-disease-and-prevention
#17
REVIEW
Kevin D Deane
PURPOSE OF REVIEW: This review discusses updates in the prediction and prevention of future rheumatoid arthritis (RA). RECENT FINDINGS: In individuals with musculoskeletal symptoms and elevated antibodies to citrullinated proteins (ACPA) without clinical inflammatory arthritis (IA), a 'simple' score has a positive predictive value (PPV) of ∼28% for clinical IA/RA within 1 year, and a comprehensive score (including ultrasound) has a PPV of ∼71% for clinical RA within 5 years...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38420886/monogenic-lupus-insights-into-disease-pathogenesis-and-therapeutic-opportunities
#18
REVIEW
Yuting Qin, Jianyang Ma, Carola G Vinuesa
PURPOSE OF REVIEW: This review aims to provide an overview of the genes and molecular pathways involved in monogenic lupus, the implications for genome diagnosis, and the potential therapies targeting these molecular mechanisms. RECENT FINDINGS: To date, more than 30 genes have been identified as contributors to monogenic lupus. These genes are primarily related to complement deficiency, activation of the type I interferon (IFN) pathway, disruption of B-cell and T-cell tolerance and metabolic pathways, which reveal the multifaceted nature of systemic lupus erythematosus (SLE) pathogenesis...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38411210/updates-on-interstitial-lung-disease-and-other-selected-extra-articular-manifestations-of-rheumatoid-arthritis
#19
REVIEW
Elena Myasoedova, Eric L Matteson
PURPOSE OF REVIEW: To discuss changes in epidemiology, recent advances in understanding of the pathogenesis and management of selected extraarticular manifestations of rheumatoid arthritis (ExRA). RECENT FINDINGS: The incidence of ExRA overall and subcutaneous rheumatoid nodules in particular is declining after 2000. These trends reflect improved RA disease activity with early effective immunosuppressive treatments; changing environmental risk factors can be contributing...
May 1, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38411201/management-of-postinfectious-inflammatory-arthritis
#20
REVIEW
Hailey Baker, J Kennedy Amaral, Robert T Schoen
PURPOSE OF REVIEW: Postinfectious inflammatory arthritis can result from various pathogens, including bacteria, viruses, fungi, and parasites. Prompt identification and treatment of acute infection is vital, but some cases progress to chronic arthritis despite successful treatment of infection. Postinfectious inflammatory arthritis varies from mild, self-limited arthralgia to severe, refractory arthritis, necessitating ongoing disease-modifying treatment. This review explores the spectrum of postinfectious inflammatory arthritis to provide insights into effective management...
May 1, 2024: Current Opinion in Rheumatology
journal
journal
30327
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.